Navigation Links
Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence

MOUNTAIN VIEW, Calif., Feb. 27, 2013 /PRNewswire/ -- Fewer breast imaging facilities in the United States, in addition to ongoing controversies surrounding breast cancer screening, has suppressed growth in the U.S. breast imaging systems market.  However, Frost & Sullivan anticipates modest expansion, driven by the increasing demand for breast imaging equipment due to the growing prevalence of breast cancer, as well as increases in breast cancer surgery procedure volumes and supplemental screening exams prompted by new breast density reporting legislation.

Click here for the full multimedia experience of this release ( 

New analysis from Frost & Sullivan's ( Analysis of the U.S. Breast Imaging Systems Market research finds that the market earned revenues of $1.0 billion in 2011 and expects this to reach $1.4 billion by 2016 at a compound annual growth rate (CAGR) of 5.8 percent.  The anticipated growth is due to growing revenues in the X-ray mammography, breast ultrasound, breast magnetic resonance imaging (MRI), and molecular breast imaging (MBI) market segments. 

If you are interested in more information on this research, please email Britni Myers , Corporate Communications, at, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

A key factor restraining market growth is consolidation of the breast imaging provider market, which has led to a smaller number of facilities in the United States.  In addition, conflicting recommendations regarding the age at which mammography screening should begin has caused hesitations regarding regular mammography screening exams by many women in their 40s.

"The number of breast imaging facilities in the United States declined by nearly 7 percent from 2002 to 2011, resulting in an even greater decline in the mammography system installed base," said Frost & Sullivan Industry Analyst Roberto Aranibar .  "This had a significant impact on market growth, given its large dependency on system replacements."

Despite these previous declines in the market, the mammography system installed base and number of breast imaging facilities in the United States appear to have begun stabilizing. New breast density notification laws, product regulatory approvals, and evolving breast cancer screening protocols are among the factors expected to drive increased replacements of mammography systems and expanded adoption of new breast imaging technologies.

"Expanding breast density reporting laws are prompting increases in supplemental screening procedure volumes that, in turn, are creating a growing demand for newer technologies that improve diagnostic accuracy, while also increasing productivity," said Aranibar.  "One such technology, automated breast ultrasound (ABUS), was recently approved for supplemental screening, and reimbursement for another such technology, breast tomosynthesis, is expected to become available soon."

Analysis of the U.S. Breast Imaging Systems Market is part of the Advanced Medical Technologies Growth Partnership Services program, which also includes research on medical devices, medical imaging equipment and informatics, patient monitoring and diagnostic tools, and chronic and acute disease management products.  All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Connect with Frost & Sullivan on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion 
Join Us:           Join our community 
Subscribe:       Newsletter on "the next big thing" 
Register:         Gain access to visionary innovation

Analysis of the U.S. Breast Imaging Systems Market

Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
2. Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon
3. Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market
4. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
7. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
8. Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria
9. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
10. Frost & Sullivan: Asia Pacific Infectious Disease Diagnostics Market Grows as Economies Boom and Countries Become Image Conscious
11. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
Post Your Comments:
(Date:10/12/2015)... , October 12, 2015 cell surface ... billion by 2022, according to a new report by Grand ... to rise in incidence of oncology diseases and other cell-associated ... is expected to reach USD 6.49 billion by 2022, according ... growth in demand can be attributed to rise in incidence ...
(Date:10/12/2015)... CAESAREA, Israel , October 12, 2015 ... of the Dario™ Diabetes Management Solution, today announced its ... a patient case study at MobiHealth,s 5th EAI ... Focused on, "Transforming healthcare through innovations in mobile and ... London, England from October 14 - ...
(Date:10/12/2015)... ... October 12, 2015 , ... NeuMedics Inc., is a specialty ... diseases that can safely and chronically be administered as an eye drop, announced today ... by The Cleveland Clinic and taking place October 25th to October 28th at The ...
(Date:10/10/2015)... Maryland , 10. Oktober, 2015 ... Matsui (Abgeordnete der Demokratischen Partei für Kalifornien) ihre ... bis 17. Oktober) in die Aufzeichnungen des Kongresses ... Plasma Protein Therapeutics Association (PPTA) und ihren ... , Hebung des Bewusstseins über Plasmaspenden weltweit ...
Breaking Biology Technology:
(Date:9/24/2015)... , September 24, 2015 ... september 2015 Kerv ( ... finanstjänster, lanserar idag världens första kontaktlösa betalningsring ... in 77 000 GBP för massproduktion via ... ) , Kerv-bärare kan ...
(Date:9/10/2015)... -- Pursuant Health has collaborated with health experts ... image-based health risk assessment (HRA) optimized for Pursuant ... assessment quantifies user results into an easily understood ... biological age based on personal health habits, characteristics ... Comprised of age, gender, and risk ...
(Date:9/8/2015)... Sept. 8, 2015  Affectiva, global leader in ... a Service, a new data solution, and version ... on Affectiva,s highly accurate and patented science, these ... slated to transform industries such as market research, ... customer experience, online education, HR, automotive, robotics, healthcare ...
Breaking Biology News(10 mins):